Pharmacokinetic behaviour of phenylglyoxal bis(guanylhydrazone) (PGBG) after intravenous administration in rabbits

J Vet Med A Physiol Pathol Clin Med. 2001 Apr;48(3):187-91. doi: 10.1046/j.1439-0442.2001.00345.x.

Abstract

Phenylglyoxal bis(guanylhydrazone) (PGBG) is a synthesized analogue of methylglyoxal bis(guanylhydrazone) (MGBG), which has demonstrated anti-parasitic activity in rabbits. The pharmacokinetic behaviour of PGBG after intravenous administration (10 mg/kg bodyweight) was studied in five rabbits. Plasma concentrations of PGBG were measured by high-performance liquid chromatography. Plasma PGBG concentrations decreased rapidly and were not detectable beyond 90 min after treatment. The mean [+/- standard deviation (SD)] volume of distribution at steady state (Vdss) was 2.19 +/- 0.47 l/kg and the mean plasma clearance value (Cl) was 29.99 +/- 3.98 ml/min kg. This drug is rapidly eliminated from the body in rabbits, having a short elimination half-life (0.93 h) and mean residence time (1.21 h).

MeSH terms

  • Animals
  • Antiparasitic Agents / administration & dosage
  • Antiparasitic Agents / pharmacokinetics*
  • Enzyme Inhibitors / administration & dosage
  • Enzyme Inhibitors / pharmacokinetics*
  • Half-Life
  • Injections, Intravenous / veterinary
  • Metabolic Clearance Rate
  • Mitoguazone / administration & dosage
  • Mitoguazone / analogs & derivatives
  • Mitoguazone / pharmacokinetics*
  • Rabbits / metabolism*

Substances

  • Antiparasitic Agents
  • Enzyme Inhibitors
  • propylglyoxal bis(guanylhydrazone)
  • Mitoguazone